Revising the ICH Guidelines on Clinical Trials

Delegation HemAffairs

Clinical trials and drug development have become more complex over the years. One complicating factor is the increased administrative burden, as was pointed out in the previous edition of HemAffairs. Doctors and clinical researchers are more and more bound to rules they deem neither necessary nor effective. At first sight, the requirements for clinical trials seem clear and thorough. Nonetheless, the interpretation and implementation of these rules leave room for improvement.

Read more

The past and future of the EU Blood, Tissues and Cells legislation

Annake HemAffairs HR

Blood, tissues and cells (BTC) are used in medicine and in hematology on a daily basis. EU legislation has been in place for over 15 years to regulate those practices, and to ensure safety and quality standards for substances of human origin (SoHO). For instance, through technical and traceability requirements for BTC, the reporting of serious adverse reactions (SARs), and verification procedures for imported BTC.

Read more

EHA at ICH meeting: Excessive bureaucracy harms patient safety and innovation

EHA delegation to ICH public meeting

To solicit input from a wide range of non-ICH members about the revision of ICH E8(R1), ICH held a Public Meeting on ICH E8(R1) “General Considerations for Clinical Studies” (Silver Spring, USA, October 31, 2019).

Read more

Meet Stefan Fröhling, our November volunteer of the month

Voulenteer of the month 2
Professor Stefan Fröhling was first introduced to EHA in 2002 when he attended the 7th EHA Congress in Florence. He has served in a number of committees and has been an EHA Board Member (2013-2017). Currently, Professor Fröhling is a member of the EHA Scientific Working Group Unit and an Associate Editor of HemaSphere, the official journal of EHA.
Meet Stefan Fröhling and learn about what he does and why he has been volunteering for EHA for all these years.
Read more

EHA returns to Cairo with the Highlights of the 24th EHA Congress

Cairo group photo HOPE MENA 2019

The 4th Highlights of Past EHA (HOPE) Middle East & North Africa (MENA) took place (for the third time) in Cairo, Egypt, organized in collaboration with the Pan Arab Hematology Association (PAHA) and hosted by the Egyptian Society of Hematology and Research (ESHR), and supported by the national hematology societies from the region, who were represented in the program as chairs of various sessions.

Read more

EHA’s Prof Jäger elected HCPWP co-chair

HCPWP co chairs Prof. Ulrich Jaeger EHA and Juan Garcia Burgos EMA

On September 24, Prof Ulrich Jäger, former EHA President and current member of the EHA European Affairs Committee, was elected as co-chair of the Health Care Professionals Working Party (HCPWP) of the European Medicines Agency (EMA). He will lead the working party during its 2019-2022 mandate alongside Juan Garcia-Burgos, EMA’s head of Public Engagement.

Read more

EHA24, another successful congress

More than 12,000 hematology professionals from around the world met together in Amsterdam, The Netherlands for the 24th European Hematology Association (EHA) Congress.

Read more

Meet Maria-Victoria Mateos, our April Volunteer of the Month

Voulenteer of the month wbsite

Maria Victoria Mateos currently heads the Scientific Program Committee of the 24th EHA Congress which will be held on June 13-16 in Amsterdam. She started volunteering for EHA in 2013 and is still an EHA Volunteer under the mentorship of Prof Jordi Sierra and current EHA President Prof Pieter Sonneveld. Why did she become a volunteer and what keeps her going? Read more.

Read more

Hematology Tutorial in Sri Lanka updates expertise on myeloid malignancies and M...

Tutorial Colombo 1

After a successful first edition in 2017, EHA and the Sri Lanka College of Haematologists (SLCH) organized its second two-day tutorial together in February in Colombo.

Read more

Uptake of CAR T cell therapy in Europe

HemAffairs DR.

Gene (editing) therapy continues to break ground in hematology, showing promising results in tackling severe blood cancers.

Read more

GAPP Joint Action

HemAffairs Blood tubes

Joint Actions are projects designed and financed by Member State Authorities and the EU to address specific priorities under the EU Health Program.

Read more

Michel Boiron 1925-2018

It is with great sadness that we announce the passing of Professor Michel Boiron last December 3. Boiron was the founding President (1992-1994) of the European Hematology Association (EHA).

Read more

Renew your EHA membership

EHA members will have the chance to renew their membership with the association from today, November 14, 2017.

Read more

European Hematology Association publishes new journal with Wolters Kluwer

Jan Cools Andreas Engert

The European Hematology Association, the largest Europe-based association of hematologists, launched its new journal HemaSphere with publisher Wolters Kluwer at the 22nd Annual Congress of EHA in Madrid.

Read more

Madrid Declaration: joint call for action on training requirements

madrid decl

The Madrid Declaration on enhanced training requirements for hematologists in the Professional Qualifications Directive enjoyed broad support from national society representatives at the EHA22 National Societies Dinner in Madrid.

Read more